Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search

Author index

Page Path
HOME > Browse Articles > Author index
Search
Don Yong Chang 2 Articles
The Effect of Dietary Intake of the Acidic Protein Fraction of Bovine Colostrum on Influenza A (H1N1) Virus Infection
Mei Ling Xu , Hyoung Jin Kim , Don Yong Chang , Hong-Jin Kim
J. Microbiol. 2013;51(3):389-393.   Published online April 26, 2013
DOI: https://doi.org/10.1007/s12275-013-2683-y
  • 671 View
  • 0 Download
  • 6 Crossref
AbstractAbstract PDF
Acidic protein levels in the milk decrease markedly as lactation progresses, suggesting that it is an important part of the colostrum. However, little attention has been paid to their biological function. In this study, we isolated the acidic protein fraction of bovine colostrum (AFC, isoelectric point <5) by anion-exchange chromatography, and investigated the effect of its dietary intake on influenza A (H1N1) virus infection. 100% of mice infected with 1 LD50 of the virus survived when administered AFC for 14 days prior to infection, compared with 33% survival when administered phosphate buffered saline (PBS). Moreover, consumption of AFC reduced the weight loss associated with infection. We propose that dietary intake of AFC has a prophylactic effect on influenza A virus infection.

Citations

Citations to this article as recorded by  
  • The Toxic Effects of Low Molecular Weight Components of Cow Colostrums: The Short-Term and Long-Term Effects
    A.I. Bozhkov, E.G. Ivanov, N.I. Kurguzova, Muhammad M.A. Alsardia, R.A. Akzhigitov, S.Ya. Baranikova, V.I. Potapova, A.S. Chuprikova
    Journal of Nutritional Therapeutics.2021; 6(4): 84.     CrossRef
  • Bovine colostrum: benefits for the human respiratory system and potential contributions for clinical management of COVID-19
    Alyne Batista da Silva Galdino, Adriano Henrique do Nascimento Rangel, Harpal Singh Buttar, Manuela Sales Lima Nascimento, Elaine Cristina Gavioli, Riva de Paula Oliveira, Danielle Cavalcanti Sales, Stela Antas Urbano, Katya Anaya
    Food and Agricultural Immunology.2021; 32(1): 143.     CrossRef
  • Influenza A in Bovine Species: A Narrative Literature Review
    Chithra C. Sreenivasan, Milton Thomas, Radhey S. Kaushik, Dan Wang, Feng Li
    Viruses.2019; 11(6): 561.     CrossRef
  • Effective Components of Bovine Colostrum and Its Applications
    Sang-Ah Seo, Hye-Ryoung Seo, Young-Tae Heo
    Journal of Animal Reproduction and Biotechnology.2018; 33(3): 159.     CrossRef
  • The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse
    Mei Ling Xu, Hyoung Jin Kim, Ga Ram Wi, Hong-Jin Kim
    Journal of Microbiology.2015; 53(9): 661.     CrossRef
  • Effect of dietary bovine colostrum on the responses of immune cells to stimulation with bacterial lipopolysaccharide
    Mei Ling Xu, Hyoung Jin Kim, Hong-Jin Kim
    Archives of Pharmacal Research.2014; 37(4): 494.     CrossRef
The Production and Immunogenicity of Human Papillomavirus Type 58 Virus-like Particles Produced in Saccharomyces cerevisiae
Hye-Lim Kwag , Hyoung Jin Kim , Don Yong Chang , Hong-Jin Kim
J. Microbiol. 2012;50(5):813-820.   Published online November 4, 2012
DOI: https://doi.org/10.1007/s12275-012-2292-1
  • 824 View
  • 0 Download
  • 15 Crossref
AbstractAbstract PDF
Human papillomavirus (HPV) is the cause of most cases of cervical cancer. HPV type 58 (HPV58) is the second most frequent cause of cervical cancer and high-grade squamous intraepithelial lesions (HSIL) in Asia and South / Central America, respectively. However, there is no vaccine against HPV58, although there are commercially available vaccines against HPV16 and 18. In this study, we produced HPV58 L1 protein from Saccharomyces cerevisiae, and investigated its immunogenicity. We first determined the optimum period of culture for obtaining HPV58 L1. We found that a considerable portion of the HPV58 L1 resulting from 48 h culture cannot be recovered by purification, while the HPV58 L1 resulting from 144 h culture is recovered efficiently: the yield of HPV58 L1 finally recovered from 144 h culture was 2.3 times higher than that from 48 h culture, although the production level of L1 protein from 144 h culture was lower than that from 48 h culture. These results indicate that the proportion of functional L1 protein from 144 h-cultured cells is significantly higher than that of 48 h-cultured cells. The HPV58 L1 purified from the 144 h culture was correctly assembled into structures similar to naturally occurring HPV virions. Immunization with the HPV58 L1 efficiently elicited anti-HPV58 neutralizing antibodies and antigen-specific CD4+ and CD8+ T cell proliferations, without the need for adjuvant. Our findings provide a convenient method for obtaining substantial amounts of highly immunogenic HPV58 L1 from S. cerevisiae.

Citations

Citations to this article as recorded by  
  • Model microorganisms: From cornerstones of modern discovery to big data-driven platforms
    Man Li, Zhongjian Song, Juan Du, Yuwei Wu, Moutong Chen, Lianying Ma, Qingping Wu
    Model Organisms Research.2026; 1(1): 100009.     CrossRef
  • Expression, purification, and immunogenicity study of human papillomavirus type 52 virus-like particles produced in Hansenula polymorpha
    Sheila Chairunnisa, Apon Zaenal Mustopa, Budiman Bela, Rosyida Khusniatul Arifah, Rifqiyah Nur Umami, Moh Egy Rahman Firdaus, Nurlaili Ekawati, Herman Irawan, Shasmita Irawan, Maritsa Nurfatwa, Ai Hertati, Sri Swasthikawati, Ela Novianti, Arizah Kusumawat
    Biologicals.2025; 90: 101831.     CrossRef
  • Yeast and Virus-like Particles: A Perfect or Imperfect Couple?
    Sara Brachelente, Alvaro Galli, Tiziana Cervelli
    Applied Microbiology.2023; 3(3): 805.     CrossRef
  • Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
    Vartika Srivastava, Kripa N. Nand, Aijaz Ahmad, Ravinder Kumar
    Vaccines.2023; 11(2): 479.     CrossRef
  • How far have we explored fungi to fight cancer?
    Chee Wun How, Yong Sze Ong, Sze Shin Low, Ashok Pandey, Pau Loke Show, Jhi Biau Foo
    Seminars in Cancer Biology.2022; 86: 976.     CrossRef
  • Yeast-based vaccines: New perspective in vaccine development and application
    Ravinder Kumar, Piyush Kumar
    FEMS Yeast Research.2019;[Epub]     CrossRef
  • Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus
    Maryam Dadar, Sandip Chakraborty, Kuldeep Dhama, Minakshi Prasad, Rekha Khandia, Sameer Hassan, Ashok Munjal, Ruchi Tiwari, Kumaragurubaran Karthik, Deepak Kumar, Hafiz M. N. Iqbal, Wanpen Chaicumpa
    Frontiers in Immunology.2018;[Epub]     CrossRef
  • The codon-optimized capsid gene of duck circovirus can be highly expressed in yeast and self-assemble into virus-like particles
    Cui YANG, Yu XU, Ren-yong JIA, Si-yang LIU, Ming-shu WANG, De-kang ZHU, Shun CHEN, Ma-feng LIU, Xin-xin ZHAO, Kun-feng SUN, Bo JING, Zhong-qiong YIN, An-chun CHENG
    Journal of Integrative Agriculture.2017; 16(7): 1601.     CrossRef
  • A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model
    Fei Yin, Yajun Wang, Na Chen, Dunquan Jiang, Yefeng Qiu, Yan Wang, Mei Yan, Jianping Chen, Haijiang Zhang, Yongjiang Liu
    Papillomavirus Research.2017; 3: 85.     CrossRef
  • EV71 virus-like particles produced by co-expression of capsid proteins in yeast cells elicit humoral protective response against EV71 lethal challenge
    Xiaowen Wang, Xiangqian Xiao, Miao Zhao, Wei Liu, Lin Pang, Xin Sun, Shan Cen, Burton B. Yang, Yuming Huang, Wang Sheng, Yi Zeng
    BMC Research Notes.2016;[Epub]     CrossRef
  • Therapeutic potential of an AcHERV-HPV L1 DNA vaccine
    Hee-Jung Lee, Jong Kwang Yoon, Yoonki Heo, Hansam Cho, Yeondong Cho, Yongdae Gwon, Kang Chang Kim, Jiwon Choi, Jae Sung Lee, Yu-Kyoung Oh, Young Bong Kim
    Journal of Microbiology.2015; 53(6): 415.     CrossRef
  • Immunogenicity of a Trivalent Human Papillomavirus L1 DNA-Encapsidated, Non-Replicable Baculovirus Nanovaccine
    Hansam Cho, Hee-Jung Lee, Yoon-Ki Heo, Yeondong Cho, Yong-Dae Gwon, Mi-Gyeong Kim, Ki Hoon Park, Yu-Kyoung Oh, Young Bong Kim, Shibo Jiang
    PLoS ONE.2014; 9(4): e95961.     CrossRef
  • The Concentration of Carbon Source in the Medium Affects the Quality of Virus-Like Particles of Human Papillomavirus Type 16 Produced in Saccharomyces cerevisiae
    Hyoung Jin Kim, Yingji Jin, Hong-Jin Kim, Paulo Lee Ho
    PLoS ONE.2014; 9(4): e94467.     CrossRef
  • Panorámica de los receptores celulares del virus del papiloma humano y su repercusión en la purificación de partículas semejantes a virus
    J.F. Beltrán-Lissabet
    Vacunas.2014; 15(1-2): 29.     CrossRef
  • Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
    Hao-Yang Li, Jian-Feng Han, Cheng-Feng Qin, Rong Chen
    Vaccine.2013; 31(32): 3281.     CrossRef

Journal of Microbiology : Journal of Microbiology
TOP